Bio-Rad Laboratories (BIO) stock
Pro members see every stock ranked and every check behind each score, live.
Why BIO scores 11
Above AverageTrending up, 4 of 14 checks firingWhat the Quality Score means
- +4Chart checks 4 of 14 firing right now, one point each
- +3Long-term trend above a rising 200-day average, near its 52-week high
- Run-up adds
- Profit adds
- Persistence adds
What's next
Expected to report Thu Oct 29, after the close
After its last 4 reports it closed -5.2% on average, higher 1 of 4 times.
What would move BIO's score: 5 things, for Pro members
Here is what Pro members see.
Every stock has a live page like this, BIO included: the price in real time, the full chart, all 14 checks, and every line of its score.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
BIO has 4 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1447.4
- MACD (12, 26, 9)Below signal
- 50-day average$365.64
- 200-day average$307.72
- ADX 1434.8
- Support$365.66
- Resistance$389.38
- Bollinger Bands (20, 2)Inside
- Volume0.9x
How BIO ranks in Life Science Tools
BIO is #9 of 16 by Quality Score among Laboratory Analytical Instruments. The top three are shown with their scores, and more by name.
RVTY6/1416
MASS8/1415
ILMN7/1414
AOpen for its score
AVTROpen for its score
BRKROpen for its score
BIO4/1411
When does BIO report earnings, and what happens after?
Expected to report Thu Oct 29, after the close (in 27 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 4, 2026After close | After close | +2.1% | +4.5% | +7.0% |
| Apr 30, 2026After close | After close | -6.7% | -8.4% | -8.1% |
| Feb 12, 2026After close | After close | -14.2% | -12.3% | -7.2% |
| Oct 29, 2025After close | After close | -1.1% | -4.7% | -3.0% |
About Bio-Rad Laboratories
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Every line of the score, on every stock.
- Real-time prices, no delay
- Every line of BIO's score, with the points and the reason
- All 14 checks on BIO and on all 3,243 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on BIO
Straight Answers.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not for the first 24 hours. Tap any green button and you're in, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.